BGM Group Ltd. (BGM) vs Insight Molecular Diagnostics Inc. (IMDX)

A side-by-side comparison of BGM Group Ltd. and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BGM vs IMDX

growth of $100 · dividends reinvested · last 2y
BGM -94.3% (-76.2%/yr)IMDX +18.0% (+8.6%/yr)IMDX compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$6$118
BGM IMDX

BGM vs IMDX: by the numbers

  • •IMDX is the larger company ($113M vs $111M market cap).
  • •Both run net losses; BGM's is the smaller (-52.59% vs -2955.63% net margin).
  • •IMDX grew revenue faster over the past five years (27.24% vs -5.39% CAGR).

Metrics side by side

Valuation

MetricBGMIMDX
P/S ratioN/A67.67
P/B ratio0.28N/A

Profitability

MetricBGMIMDX
Gross margin12.79%11.17%
Operating margin-33.18%-754.08%
Net margin-52.59%-2955.63%
ROE-5.10%N/A
ROIC-3.19%-223.06%

Growth (annualized)

MetricBGMIMDX
Revenue CAGR (5Y)-5.39%27.24%
Total return CAGR (5Y)N/A-44.39%

Frequently asked

Which has grown faster, BGM or IMDX?
Over the past five years, IMDX grew revenue faster — BGM at a -5.39% CAGR versus IMDX at 27.24%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.